Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sustained release emphasizing recombinant human bone morphogenetic protein-2.

Hollinger1, Uludag, Winn

  • 1Division of Plastic and Reconstructive Surgery, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97201-3098, USA

Advanced Drug Delivery Reviews
|June 6, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transverse momentum and total cross section of e(+)e(-) pairs in the Z-boson region from p&pmacr; collisions at sqrt

Physical review letters·2000
Same author

Response of Osteosarcoma to Chemotherapy. Evaluation with F-18 FDG-PET Scans.

Clinical positron imaging : official journal of the Institute for Clinical P.E.T·2000
Same author

The Functional Significance and Fitness Consequences of Heterophylly.

International journal of plant sciences·1999
Same author

A dielectric omnidirectional reflector

Science (New York, N.Y.)·1998
Same author

Influence of the Dufour effect on convection in binary gas mixtures.

Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics·1995
Same author

X-ray-photoelectron-diffraction study of InAs/InP(001) heterostructures.

Physical review. B, Condensed matter·1994
Same journal

Silicone oil in protein drug products and its implications for formulation stability.

Advanced drug delivery reviews·2026
Same journal

Targeted delivery of proteolysis-targeting chimeras (PROTAC) and molecular glue degraders (MGD).

Advanced drug delivery reviews·2026
Same journal

Lysosome-targeting degrader delivery system: from formulation design to biomedical applications.

Advanced drug delivery reviews·2026
Same journal

Anti-PEG antibodies in nanomedicine: Mechanisms, risks, and opportunities.

Advanced drug delivery reviews·2026
Same journal

Optimizing macrophage-targeted intracellular delivery systems for safe and effective immunotherapies.

Advanced drug delivery reviews·2026
Same journal

Light-controlled CRISPR-dCas9 epigenome editing: advanced drug-delivery strategies and oncology applications.

Advanced drug delivery reviews·2026
See all related articles

Bone morphogenetic proteins (BMPs) show promise for bone regeneration, but their effectiveness relies on controlled delivery. This review explores recombinant human BMP-2 in sustained release systems for enhanced bone repair therapies.

Area of Science:

  • Orthopedics
  • Biomaterials Science
  • Regenerative Medicine

Background:

  • Bone homeostasis is a complex biological process regulated by various factors.
  • Severe bone injuries often exceed natural regenerative capacity, necessitating therapeutic interventions.
  • Conventional bone grafting methods have limitations and high failure rates.

Purpose of the Study:

  • To review the current applications of bone morphogenetic proteins (BMPs) in bone regeneration.
  • To explore the potential of sustained release carrier systems for BMPs in clinical settings.

Main Methods:

  • Literature review on BMPs and bone regeneration.
  • Discussion of carrier systems for localized and sustained BMP delivery.
  • Focus on recombinant human BMP-2 (rhBMP-2) applications.

Related Experiment Videos

Main Results:

  • BMPs are potent osteogenic molecules that can enhance bone regeneration.
  • Sustained release systems are crucial for optimizing BMP therapeutic efficacy.
  • rhBMP-2 shows significant potential when delivered via well-characterized carriers.

Conclusions:

  • Optimizing BMP delivery through sustained release carriers is key to improving bone regeneration outcomes.
  • rhBMP-2 delivered via sustained release systems offers a promising alternative to conventional therapies for bony deficits.